These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19571803)

  • 1. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century.
    Septimus EJ; Kuper KM
    Clin Pharmacol Ther; 2009 Sep; 86(3):336-9. PubMed ID: 19571803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current challenges in antibiotic resistance.
    Hand WL
    Adolesc Med; 2000 Jun; 11(2):427-38. PubMed ID: 10916132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences.
    Siegel RE
    Respir Care; 2008 Apr; 53(4):471-9. PubMed ID: 18364060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus. Mechanisms of resistance and implications for treatment.
    Chambers HF
    Postgrad Med; 2001 Feb; 109(2 Suppl):43-50. PubMed ID: 19667557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of selected plant species from "the Argentine Puna" against sensitive and multi-resistant bacteria.
    Zampini IC; Cuello S; Alberto MR; Ordoñez RM; D' Almeida R; Solorzano E; Isla MI
    J Ethnopharmacol; 2009 Jul; 124(3):499-505. PubMed ID: 19467313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of antibiotic-resistant Gram-positive pathogens.
    Lode HM
    Clin Microbiol Infect; 2009 Mar; 15(3):212-7. PubMed ID: 19335368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in antimicrobial resistance in intensive care units in the United States.
    Prabaker K; Weinstein RA
    Curr Opin Crit Care; 2011 Oct; 17(5):472-9. PubMed ID: 21900766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures.
    Stein GE
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):44S-54S. PubMed ID: 16178675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria.
    Raad I; Reitzel R; Jiang Y; Chemaly RF; Dvorak T; Hachem R
    J Antimicrob Chemother; 2008 Oct; 62(4):746-50. PubMed ID: 18653489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of antimicrobial resistance on the treatment and outcome of patients with sepsis.
    Figueiredo Costa S
    Shock; 2008 Oct; 30 Suppl 1():23-9. PubMed ID: 18704013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
    Bishburg E; Bishburg K
    Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global view of antimicrobial resistance. Findings of the SENTRY Antimicrobial Surveillance Program, 1997-1999.
    Pfaller MA; Jones RN
    Postgrad Med; 2001 Feb; 109(2 Suppl):10-21. PubMed ID: 19667553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for MRSA with reduced susceptibility to vancomycin.
    Med Lett Drugs Ther; 2009 May; 51(1311):36; quiz 37. PubMed ID: 19417720
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Sparo MD; Jones DG; Sánchez Bruni SF
    Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of 5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenylporphine in supramolecular aggregates of cationic amphiphilic cyclodextrins: physicochemical characterization of the complexes and strengthening of the antimicrobial photosensitizing activity.
    Ferro S; Jori G; Sortino S; Stancanelli R; Nikolov P; Tognon G; Ricchelli F; Mazzaglia A
    Biomacromolecules; 2009 Sep; 10(9):2592-600. PubMed ID: 19637910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
    Rahal JJ
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S4-S10. PubMed ID: 19619021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants.
    Mitrano JA; Spooner LM; Belliveau P
    Pharmacotherapy; 2009 Sep; 29(9):1103-9. PubMed ID: 19698015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of P-triazinylphosphonium salts--hybrid molecules with potential antimicrobial activity.
    Kolesińska B; Motylski R; Kamiński ZJ; Kwinkowski M; Kaca W
    Acta Pol Pharm; 2011; 68(3):387-91. PubMed ID: 21648193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.